Overview

Naproxen Sodium/ASA Platelet Study

Status:
Completed

Trial end date:
2015-05-01

Target enrollment:

Participant gender:

Summary

To determine if administration of naproxen sodium 220 mg maintains the platelet inhibitory effect of a low dose Immediate Release Aspirin (IR ASA) regimen.

Phase:

Phase 1

Details

Lead Sponsor:

Bayer

Treatments:

Aspirin
Naproxen